O. Semenova et al.
Dyes and Pigments 195 (2021) 109745
Hz, 2H), 1.84–1.67 (m, 2H), 1.62 (s, 12H), 1.67–1.53 (m, 2H), 1.50–1.35
(m, 2H). 13C NMR (100 MHz, CDCl3–CD3OD, ppm): δ 175.63 (COOH),
171.14 (CN Ind), 170.56 (CN Ind) 155.75 (CH), 150.53 (2CH), 141.67
(Ar), 141.00 (Ar), 139.80 (Ar), 139.63 (Ar), 127.84 (2CH Ar), 124.76
(2CH), 124.26 (2CH Ar), 121.36 (CH Ar(, 121.23 (CH Ar), 109.50 (CH
Ar), 109.40 (CH Ar), 102.68 (CH), 102.42 (CH), 48.47 (2C(CH3)2), 43.09
(CH2), 32.98 (CH2), 30.23 (CH3), 26.83 (4CH3), 26.19 (CH2), 25.45
(CH2), 23.58 (CH2). HRMS m/z (ESI+) C34H40N2O2 calculated [M+H]+
509.3090 (509.3163), found m/z: 509.3168.
7.0 Hz, 2H), 3.95 (t, J = 6.8 Hz, 2H), 3.43 (t, J = 7.9, 2H), 3.26 (m, 6H)
2.30 (t, J = 7.2 Hz, 2H,), 2.04 (m, 2H), 1.77 (m, 2H), 1.66 (m, 2H), 1.64
(s, 6H), 1.61 (s, 6H), 1.45 (m, 2H), 1.27 (t, J = 7.1 Hz, 9H). HRMS m/z
(ESI+) C44H56F3I2N3O4 calculated [M–CF3COO]+ 888.2451 (888.2445),
found m/z: 888.2462.
6-(3,3-Dimethyl-2-(7-(4,5,6-triiodo-1,3,3-trimethylindolin-2-
ylidene)hepta-1,3,5-trien-1-yl)-3H-indol-1-ium-1-yl)hexanoate
(3ICy7). Dye 3ICy7 was synthesized from 4,5,6-triiodo-1,2,3,3-tetra-
methyl-3H-indol-1-ium iodide (1c) (170 mg, 0.25 mmol), N-[5-(phe-
nylamino)-2,4-pentadienylidene]aniline hydrochloride (65 mg, 0.23
mmol), and 1-(5-carboxypentyl)-2,3,3-trimethyl-3H-indol-1-ium bro-
mide (3a) (88.0 mg, 0.25 mmol). Yield: 75 mg (37%). 1H NMR (400
MHz, CDCl3–CD3OD, ppm): δ 7.82 (t, J = 12.4 Hz, 1H), 7.54 (t, J = 13.0
Hz, 1H), 7.50 (s, 1H), 7.40 (d, J = 7.7 Hz, 2H), 7.40 (t, J = 12.6 Hz, 1H),
7.31 (t, J = 7.6 Hz, 1H), 7.25 (d, J = 7.8 Hz, 1H), 6.59 (t, J = 12.6 Hz,
1H), 6.43 (t, J = 12.5 Hz, 1H), 6.36 (d, J = 13.5 Hz, 1H), 5.77 (d, J =
13.1 Hz, 1H), 4.07 (t, J = 7.2 Hz, 2H), 3.31 (s, 3H), 2.22 (t, J = 7.2 Hz,
2H), 1.79 (m, 2H), 1.69 (s, 6H), 1.65 (s, 6H), 1.64 (m, 2H), 1.45 (m, 2H).
13C NMR (100 MHz, CDCl3–CD3OD, ppm): δ 177.20 (COOH), 174.33
(CN Ind), 166.58 (CN Ind), 155.22 (CH), 153.27 (CH), 146.81 (CH),
144.47 (Ar), 141.28 (Ar), 140.59 (Ar), 140.34 (Ar), 128.28 (CH Ar),
126.34 (CH), 126.11 (CH), 125.57 (CH Ar), 121.54 (CH Ar), 118.83
(2CH Ar), 116.77 (CI Ar), 111.04 (2CI Ar), 105.96 (CH), 101.98 (CH),
50.51 (C(CH3)2), 49.30 (C(CH3)2), 44.03 (CH2), 34.28 (CH2), 28.73
(CH3), 26.58 (CH2), 26.50 (2CH3), 25.42 (CH2), 23.98 (CH2), 23.29
(2CH3). HRMS m/z (ESI+) C34H37I3N2O2 calculated [M+H]+ 886.9989
(887.0062), found m/z: 887.0067.
6-(2-(7-(5-iodo-1,3,3-trimethylindolin-2-ylidene)hepta-1,3,5-
trien-1-yl)-3,3-dimethyl-3H-indol-1-ium-1-yl)hexanoate (1ICy7).
Dye 1ICy7 was synthesized from 5-iodo-1,2,3,3-tetramethyl-3H-indol-1-
ium iodide (1b) (106.75 mg, 0.25 mmol), N-[5-(phenylamino)-2,4-
pentadienylidene]aniline hydrochloride (64 mg, 0.23 mmol), and 1-(5-
carboxypentyl)-2,3,3-trimethyl-3H-indol-1-ium bromide (3a) (88.5 mg,
0.25 mmol). Yield: 74 mg (45%). 1H NMR (400 MHz, CDCl3–CD3OD,
ppm): δ 7.76 (t, J = 13.1 Hz, 1H), 7.61 (t, J = 13.1 Hz, 1H), 7.59 (d, J =
8.5 Hz, 1H), 7.54 (s, 1H), 7.40 (t, J = 12.7 Hz, 1H), 7.37 (t, J = 7.9 Hz,
1H), 7.36 (d, J = 7.8 Hz, 1H), 7.25 (t, J = 7.4 Hz, 1H), 7.15 (d, J = 7.9
Hz, 1H), 6.77 (d, J = 8.4 Hz, 1H), 6.53 (t, J = 13.3 Hz, 1H), 6.44 (t, J =
13.3 Hz, 1H), 6.20 (d, J = 13.5 Hz, 1H), 5.92 (d, J = 13.3 Hz, 1H), 3.99
(t, J = 7.4 Hz, 2H), 3.42 (s, 3H), 2.24 (t, J = 7.2 Hz, 2H), 1.77 (m, 2H),
1.64 (m, 2H), 1.63 (s, 6H), 1.58 (s, 6H), 1.44 (m, 2H). 13C NMR (100
MHz, CDCl3–CD3OD, ppm): δ 176.41 (COOH), 172.48 (CN Ind), 168.14
(CN Ind), 155.64 (CH), 152.05 (2CH), 148.66 (CH), 141.83 (Ar), 141.46
(Ar), 140.63 (Ar), 140.16 (Ar), 136.45 (CH Ar), 130.15 (CH Ar), 128.06
(CH Ar), 125.46 (CH Ar), 125.20 (CH), 122.42 (CH Ar), 110.53 (CH Ar),
110.27 (CH Ar), 104.14 (CH), 101.49 (CH), 86.19 (CI Ar), 48.73 (C
(CH3)2), 47.05 (C(CH3)2), 43.54 (CH2), 33.74 (CH2), 29.95 (CH3), 26.86
(2CH3), 26.67 (2CH3), 26.35 (CH2), 25.42 (CH2), 23.80 (CH2). HRMS m/
z (ESI+) C34H39IN2O2 calculated [M+H]+ 635.2056 (635.2129), found
m/z: 635.2134.
6-(5-Iodo-3,3-dimethyl-2-(7-(4,5,6-triiodo-1,3,3-trimethylindo-
lin-2-ylidene)hepta-1,3,5-trien-1-yl)-3H-indol-1-ium-1-yl)hex-
anoate (4ICy7). Dye 4ICy7 was synthesized from 4,5,6-triiodo-1,2,3,3-
tetramethyl-3H-indol-1-ium iodide (1c) (170 mg, 0.25 mmol), N-[5-
(phenylamino)-2,4-pentadienylidene]aniline hydrochloride (65 mg,
0.23 mmol), and 1-(5-carboxypentyl)-5-iodo-2,3,3-trimethyl-3H-indol-
1-ium bromide (3b) (120 mg, 0.25 mmol). Yield: 116 mg (50%). 1H
NMR (400 MHz, CDCl3–CD3OD, ppm): δ 7.78 (t, J = 12.8 Hz, 1H), 7.68
(d, J = 8.3 Hz, 1H), 7.66 (s, 1H), 7.63 (t, J = 13.0 Hz, 1H), 7.57 (s, 1H),
7.43 (t, J = 12.7 Hz, 1H), 6.96 (d, J = 8.4 Hz, 1H), 6.58 (t, J = 12.6 Hz,
1H), 6.48 (t, J = 12.6 Hz, 1H), 5.23 (d, J = 13.4 Hz, 1H), 5.88 (d, J =
13.3 Hz, 1H), 3.98 (t, J = 7.8 Hz, 2H), 3.37 (s, 3H), 2.24 (t, J = 7.2 Hz,
2H), 1.74 (m, 2H), 1.70 (s, 6H), 1.62 (s, 6H), 1.52 (m, 2H), 1.42 (m, 2H).
13C NMR (100 MHz, CDCl3–CD3OD, ppm): δ 177.01 (COOH), 172.11
(CN Ind), 168.49 (CN Ind), 156.17 (CH), 152.62 (CH), 148.84 (CH),
144.13 (Ar), 142.34 (Ar), 141.45 (Ar), 140.42 (Ar), 137.03 (CH Ar),
130.63 (CH Ar), 126.44 (2CH), 119.32 (CH Ar), 118.06 (CI Ar), 112.19
(CH Ar), 105.56 (CI Ar), 104.78 (CH), 102.10 (CI Ar), 101.18 (CH),
89.21 (CI Ar), 50.99 (C(CH3)2), 48.72 (C(CH3)2), 43.70 (CH2), 33.48
(CH2), 28.42 (CH3), 26.60 (2CH3), 26.38 (CH2), 25.32 (CH2), 23.66
(CH2), 23.16 (2CH3). HRMS m/z (ESI+) C34H36I4N2O2 calculated
[M+H]+ 1012.8956 (1012.9028), found m/z: 1012.9034.
6-(5-Iodo-2-(7-(5-iodo-1,3,3-trimethylindolin-2-ylidene)hepta-
1,3,5-trien-1-yl)-3,3-dimethyl-3H-indol-1-ium-1-yl)hexanoate
(2ICy7). Dye 2ICy7 was synthesized from 5-iodo-1,2,3,3-tetramethyl-
3H-indol-1-ium iodide (1b) (106.5 mg, 0.25 mmol), N-[5-(phenyl-
amino)-2,4-pentadienylidene]aniline hydrochloride (64 mg, 0.23
mmol), and 1-(5-carboxypentyl)-5-iodo-2,3,3-trimethyl-3H-indol-1-ium
bromide (3b) (120 mg, 0.25 mmol). Yield: 65 mg (38%). 1H NMR (400
MHz, CDCl3–CD3OD, ppm): δ 7.71 (t, J = 13.0 Hz, 2H), 7.63 (d, J = 8.3
Hz, 2H), 7.60 (s, 2H), 7.45 (t, J = 12.7 Hz, 1H), 6.87 (d, J = 8.2 Hz, 1H),
6.85 (d, J = 8.1 Hz, 1H), 6.51 (t, J = 12.1 Hz, 2H), 6.08 (d, J = 12.7 Hz,
1H), 6.06 (d, J = 13.5 Hz, 1H), 3.90 (t, J = 7.2 Hz, 2H), 3.49 (s, 3H), 2.23
(t, J = 7.2 Hz, 2H), 1.72 (m, 2H), 1.64 (m, 2H), 1.60 (s, 12H), 1.42 (m,
2H). 13C NMR (100 MHz, CDCl3–CD3OD, ppm): δ 176.74 (COOH),
170.26 (CN Ind), 169.74 (CN Ind), 156.26 (CH), 150.81 (CH), 150.69
(CH), 142.00 (Ar), 141.75 (Ar), 141.53 (Ar), 140.86 (Ar), 136.73 (2CH
Ar), 130.45 (CH Ar), 130.31 (CH Ar), 125.65 (2CH), 111.38 (CH Ar),
111.25 (CH Ar), 103.08 (CH), 102.86 (CH), 87.63 (CI Ar), 88.52 (CI Ar),
48.2 (2C(CH3)2), 43.18 (CH2), 33.48 (CH2), 30.34 (CH3), 26.78 (4CH3),
26.12 (CH2), 25.43 (CH2), 23.73 (CH2). HRMS m/z (ESI+) C34H38I2N2O2
calculated [M+H]+ 761.1023 (761.1095), found m/z: 761.1101.
6-(5-Iodo-2-(7-(5-iodo-3,3-dimethyl-1-(3-(triethylammonio)
propyl)indolin-2-ylidene)hepta-1,3,5-trien-1-yl)-3,3-dimethyl-3H-
indol-1-ium-1-yl)hexanoate trifluoroacetate (2ICy7þ). Dye 2ICy7þ
was synthesized from 5-iodo-2,3,3-trimethyl-1-(3-(triethylammonio)
propyl)-3H-indol-1-ium dibromide (1d) (147 mg, 0.25 mmol), N-[5-
(phenylamino)-2,4-pentadienylidene]aniline hydrochloride (65 mg,
0.23 mmol), and 1-(5-carboxypentyl)-5-iodo-2,3,3-trimethyl-3H-indol-
1-ium bromide (3b) (120 mg, 0.25 mmol). The product was purified on a
RP18 column (acetonitrile–water + 0.05% TFA). Yield: 34 mg (15%). 1H
NMR (400 MHz, CDCl3–CD3OD, ppm): δ 7.74 (t, J = 13.0 Hz, 1H), 7.70
(d, J = 8.3 Hz, 1H), 7.68 (t, J = 13.0 Hz, 1H), 7.66 (s, 1H), 7.64 (d, J =
8.1 Hz, 1H), 7.59 (s, 1H), 7.40 (t, J = 12.8 Hz, 1H), 7.01 (d, J = 8.3 Hz,
1H), 6.91 (d, J = 8.3 Hz, 1H), 6.60 (t, J = 12.7 Hz, 1H), 6.55 (t, J = 12.8
Hz, 1H), 6.28 (d, J = 13.2 Hz, 1H), 6.15 (d, J = 13.5 Hz, 1H), 4.08 (t, J =
6-(4,5,6-Triiodo-3,3-dimethyl-2-(7-(4,5,6-triiodo-1,3,3-trime-
thylindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-3H-indol-1-ium-1-yl)
hexanoate (6ICy7). Dye 6ICy7 was synthesized from 4,5,6-triiodo-
1,2,3,3-tetramethyl-3H-indol-1-ium iodide (1c) (170 mg, 0.25 mmol),
N-[5-(phenylamino)-2,4-pentadienylidene]aniline hydrochloride (65
mg, 0.23 mmol), and 1-(5-carboxypentyl)-4,5,6-triiodo-2,3,3-trimethyl-
3H-indol-1-ium bromide (3c) (183 mg, 0.25 mmol). Yield: 78 mg (27%).
1H NMR (400 MHz, CDCl3–CD3OD, ppm): δ 7.73 (t, J = 13.0 Hz, 2H),
7.65 (s, 1H), 7.62 (s, 1H), 7.45 (t, J = 12.6 Hz, 1H), 6.57 (m, 2H), 6.06
(d, J = 13.5 Hz, 2H), 3.86 (t, J = 7.6 Hz, 2H), 3.47 (s, 3H), 2.26 (t, J =
7.1 Hz, 2H), 1.72 (s, 12H), 1.68 (m, 2H), 1.63 (m, 2H), 1.42 (m, 2H). 13
C
NMR (100 MHz, CDCl3–CD3OD, ppm): 177.05 (COOH), 170.80 (2CN
Ind), 156.82 (CH), 151.90 (CH), 151.50 (CH), 143.68 (Ar), 142.93 (Ar),
141.94 (Ar), 141.70 (Ar), 120.03 (2CH), 119.95 (2CH Ar), 119.54 (2CI
Ar), 105.95 (CI Ar), 105.75 (CI Ar), 102.86 (2CI Ar), 102.45 (CH),
102.22 (CH), 51.72 (C(CH3)2), 51.57 (C(CH3)2), 43.08 (CH2), 33.57
(CH2), 28.72 (CH3), 25.81 (CH2), 25.22 (CH2), 23.68 (CH2), 23.01
3